Key facts
| Price (PPV) | 22,044 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | cabazitaxel |
| Class | Antineoplastic agents |
| ATC code | L01CD04 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Flacon de 1.5 ml |
| Nature | Médicament |
| Hospital price | 21,619 MAD |
| Data collected on | 9/8/2026 |
Indications
En association avec la prednisone ou la prednisolone, JEVTANA est indiqué pour le traitement de patients atteints d'un cancer métastatique de la prostate résistant à la castration (mCRPC) ayant été traités au préalable avec une chimiothérapie à base de docétaxel.
Find an open pharmacy
On-call pharmacies near you
About Jevtana 60 mg / 1.5 ml
Jevtana 60 mg / 1.5 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Jevtana 60 mg / 1.5 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Jevtana 60 mg / 1.5 ml
Answers to common questions from Moroccan patients about this drug.